The Middle East and Africa Diabetic Footwear market is anticipated to grow at more than 6.93% CAGR from 2026 to 2031.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • CAGR (2026-2031): 6.93
  • Largest Market: Saudi Arabia
  • Fastest Market: United Arab Emirates
  • Format: PDF & Excel
Featured Companies
  • 1 . Apex Foot Health Industries, LLC
  • 2 . Enovis
  • 3 . Propet USA, Inc.
  • 4 . 3M Company
  • 5 . Essity AB
  • 6 . Simcan Enterprises Inc
  • More...

Market Analysis

The market for diabetic footwear in the MEA region is on an upward trajectory, as it is expected to grow at a strong annual rate in the coming years, fueled by the increasing number of diabetes cases and higher healthcare funding. In the Gulf Cooperation Council nations, the latest growth of diabetic care facilities and dedicated sections in hospitals has sparked a greater need for medical footwear. Meanwhile, in African countries, non-governmental organizations and health initiatives are working to promote preventative diabetic treatments, which include the provision of custom-made and budget-friendly shoes. Advancements like breathable and heat-resistant shoes for diabetics are becoming popular in this area, catering to the specific needs of patients in the region and improving adherence to treatment. Key companies such as Dr. Comfort, MediFoot, and regional producers are enhancing their distribution networks and forming collaborations with hospitals, clinics, and online marketplaces to boost product availability. Strategic moves like partnerships with podiatrists, orthotic experts, and governmental health programs are also facilitating wider acceptance, especially in cities. , the market is gaining from a rise in public understanding of foot health's role in managing diabetes, which is driven by educational initiatives and online campaigns. With advancements in healthcare, increasing personal incomes, and a growth in retail outlets, the MEA area offers ample opportunities for companies to launch innovative diabetic footwear tailored to the region. The conjunction of unmet patient requirements, climate adaptations, and active health strategies positions the MEA diabetic footwear market as a significant area for growth in diabetes management, providing both economic and social benefits. According to the research report, " Middle East and Africa Diabetic Footwear Market Research Report, 2031," published by Actual Market Research, the Middle East and Africa Diabetic Footwear market is anticipated to grow at more than 6.93% CAGR from 2026 to 2031. The diabetic footwear sector in the MEA region is projected to experience consistent growth, driven by an increase in hospital purchases of specialized shoes and collaborations with orthotic providers aimed at enhancing patient results.

In Gulf Cooperation Council nations, medical institutions are progressively incorporating diabetic footwear within standard patient treatment plans, while awareness initiatives in both urban and rural African settings are enlightening patients about potential foot issues, thereby boosting the need for preventive footwear. Improvements in technology, such as the development of heat-resistant and breathable fabrics, are making products more attractive and efficient, particularly in warmer areas. Significant players in the market, like Dr. Comfort and MediFoot, along with local manufacturers, are broadening their reach through collaborations with hospitals, clinics, and medical distributors to connect with a larger audience. Access to retail is also enhancing through online platforms and pharmacy networks, increasing the availability of therapeutic footwear for patients throughout the region. New healthcare frameworks in various MEA countries are dedicating resources to state-of-the-art facilities and specialized diabetes care units, generating more opportunities for the use of diabetic shoes. Growing understanding of foot complications related to diabetes, alongside rising disposable incomes and urban development, is motivating patients to purchase high-quality footwear that helps minimize the risk of ulcers, infections, and amputations. Government programs and initiatives led by non-governmental organizations are supporting commercial activities, especially in areas that lack sufficient resources. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Increasing Diabetes Cases: The rise in diabetes prevalence within the Middle East and Africa significantly fuels the demand for shoes designed for diabetics. As more individuals are diagnosed with diabetes, the requirement for special footwear to keep feet safe from injuries, ulcers, and infections also rises, establishing diabetic shoes as a vital component of foot health.

• Enhanced Awareness Regarding Foot Health & Prevention: The growing understanding among the public and healthcare providers about the issues related to diabetic foot conditions is encouraging the use of specialized shoes. Both patients and medical professionals are increasingly acknowledging the significance of preventive actions to lessen costly and severe complications. Market Challenges

• Limited Awareness and Education: Numerous diabetic individuals, particularly in rural and disadvantaged locations, lack sufficient knowledge about the advantages of diabetic footwear. This lack of understanding hampers market growth and delays the uptake of these shoes until complications arise.

• Cost and Accessibility Obstacles : Specialized shoes for diabetics typically have a higher price tag than standard footwear due to their unique materials and intricate design. In many areas of MEA, inadequate insurance and lower income levels make these shoes hard for patients to purchase or easily obtain. Market Trends

• Increasing Emphasis on Preventive Healthcare: Both patients and health professionals are progressively recognizing diabetic footwear as a preventive measure, leading to earlier use and better incorporation of shoe suggestions in diabetes management plans.

• Rise of Online Shopping and Retail Availability: The expansion of online shopping and improved distribution systems is enhancing access to diabetic footwear across urban centers and even semi-urban regions, helping to address issues related to availability and selection.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Segmentation

By Product Slippers
Sandals
Shoes
Others(Socks)
By Foot Condition Neuropathy
Ulcers
Deformities
By Distribution Channel Offline
Online
By End User Men
Women
Kids
MEA North America
Europe
Asia-Pacific
South America
MEA



Shoes are the top choice because they provide the best protection, support, and flexibility for the daily and medical requirements of those with diabetes, promoting higher usage than other types of products.

In the MEA diabetic footwear market, the shoes represent the largest category of products because they meet the main functional and medical needs that people with diabetes consider important. Diabetic shoes typically include characteristics such as added depth, cushioned soles that absorb shocks, seamless designs, and sturdy construction, which assist in evenly distributing weight, minimizing irritation, and avoiding skin damage or ulcers more efficiently than sandals, slippers, or socks. These features are particularly crucial for managing typical foot issues related to diabetes like neuropathy, poor blood circulation, and deformities, all of which require substantial foot coverage to lower the risk of injury. When compared to sandals or lighter shoes, footwear provides complete coverage of the feet, which helps protect against dangers in the environment such as rough ground or accidental bumps delivering both safety and suitable style for everyday activities, workplaces, and medical visits. In many MEA regions with different climates and job requirements, this blend of safety and versatility makes shoes the preferred option for most diabetic footwear purchases. Shoes are frequently the first type of therapeutic footwear suggested by health professionals because they can be precisely fitted and adjusted for orthotic inserts or personalized supports. This professional backing enhances consumer confidence and preference. Although categories like sandals may be expanding thanks to lifestyle choices and comfort, shoes continue to be the leading option because they focus on preventive care and avoiding complications, which are key issues in managing foot health for diabetics.

The neuropathy category is at the forefront because diabetic peripheral neuropathy represents one of the most frequent and severe foot complications, leading to a significant need for protective footwear aimed at minimizing risks from nerve damage.

In the diabetic footwear market in MEA and footwear designed for neuropathy constitutes the largest and often the quickest-growing category of foot conditions. The main reason for this is that diabetic peripheral neuropath which is nerve damage resulting from chronic high blood sugar levels is one of the most usual complications of diabetes, impacting a large number of individuals with diabetes. This condition often leads to a decrease in feeling or numbness in the feet, preventing patients from noticing injuries, pressure sores, or irritation. If these minor issues are not managed, they can swiftly escalate into ulcers, infections, and even result in amputation. Diabetic shoes made for neuropathy have characteristics like roomy toe areas, deeper designs, added cushioning, and smooth linings to minimize any friction and pressure spots. These features are essential due to the fact that neuropathy affects pain awareness, meaning patients might not feel harmful pressure until some damage has taken place. By offering a protective layer, neuropathy-specific shoes help break the cycle of unnoticed injuries and serious complications. In the MEA region, where the rate of diabetes is increasing, both patients and caregivers have become more aware of the dangers of neuropathy, leading to a higher demand for shoes designed to combat the effects of nerve damage. Healthcare providers frequently suggest these protective styles as a common preventive measure in diabetic foot care, highlighting their significance in treatment and everyday life. Consequently, the neuropathy category is growing faster than other conditions like ulcers or deformities in terms of current demand and future growth, as it caters to the essential need for early risk management and ongoing care of diabetic foot issues.

The offline retail sector stands as the leading channel because buying diabetic shoes generally necessitates face-to-face fitting, expert advice, and professional assistance, which patients favor over online alternatives.

Within the MEA diabetic footwear sector, offline sales channels such as specialty shops, healthcare clinics, pharmacies, and specific shoe retailers take the largest portion of the market. The main reason for this is the type of product diabetic shoes are frequently medically recommended or prescribed and need exact fitting, material assessment, and sometimes modifications to fit individual foot shapes or medical conditions. These needs are best managed in a brick-and-mortar setting where patients can try items, get help from qualified professionals (like podiatrists or orthotic experts), and receive on-site adjustments. For those with diabetes, particularly individuals with neuropathy or a history of foot problems, a poor fit can result in pressure points, discomfort, or even sores. Both healthcare providers and shoppers often view offline methods as safer and more dependable due to the ability to check the fit, comfort, and medical relevance before making a purchase something that online shopping can’t always provide. In various areas of the MEA, offline retail also enjoys the advantages of established trust levels, brand recognition, and long-term connections between patients and specialized clinics or stores. Older adults and individuals with health or mobility challenges may prefer shopping offline, where they can consult with professionals and feel assured about the quality and suitability of products.

The men's group is the largest because men tend to have a higher occurrence of diabetes and related foot issues, leading to a greater need for therapeutic shoes compared to other user groups.

In both the MEA and markets for diabetic footwear, the men's end-user category consistently holds the largest revenue share. A key reason for this is epidemiological various market studies show that men are statistically more prone to diabetes and particularly issues like neuropathy that require specialist shoes. This demand translates into increased needs for therapeutic footwear specifically designed for male foot shapes and medical requirement. Furthermore, footwear designs for men often focus on wider toe boxes, enhanced support, and greater load-bearing abilities characteristics that align with male foot structure and walking styles because these attributes directly meet practical needs such as even pressure distribution, stability support, and lower chances of foot injuries, male shoppers typically exhibit stronger and more consistent buying habits. Men may seek healthcare assistance later in their disease progress or encounter complications like neuropathy more often, which can lead to more clinical recommendations for therapeutic footwear ultimately increasing market share in this area. Healthcare findings indicate that men commonly face higher risks of peripheral vascular disease, neuropathy, and other foot-related issues, which amplifies the necessity for protective footwear. Moreover, studies on consumer habits reveal that male diabetic patients usually prioritize functional protective footwear over style options, particularly when advised by healthcare professionals. In contrast, other user groups like women may experience faster growth rates due to lifestyle and fashion trends, yet the established prevalence of diabetes complications in men maintains the men's segment as the largest user category in terms of current market revenue.

Market Regional Insights


Saudi Arabia ranks first in the MEA diabetic footwear sector due to its high diabetes rates in the region, strong investments in healthcare, increasing awareness of complications from diabetes, and growing initiatives for preventive care.

Saudi Arabia is at the forefront of the Middle East & Africa (MEA) diabetic footwear sector, primarily because it is confronted with a notably high rate of diabetes, which drives the need for specialized foot care products. Research statistics show that the nation has one of the highest occurrences of type 2 diabetes, not only within the MEA but also ranks among the highest ly, with adult rates significantly exceeding regional norms. With more people developing diabetes, related issues like peripheral neuropathy, inadequate blood flow, and diabetic foot ulcers become more prevalent conditions that markedly boost the demand for therapeutic and protective footwear that helps avoid injuries, alleviate pressure, and enhance daily movement for those affected. In terms to medical needs, the well-established healthcare system and growing public health efforts in Saudi Arabia contribute to the expansion of the diabetic footwear market. Government health initiatives and national strategies aimed at diabetes prevention stress the importance of early diagnosis and thorough management of chronic conditions, which includes foot care education and the encouragement of preventive products. This institutional drive helps increase both the awareness and acceptance of diabetic footwear amongst patients, healthcare providers, and caregivers. Consumer interest is also shaped by rising incomes and greater healthcare investments in the kingdom, allowing more people to afford quality diabetic care products. As patients gain more knowledge about the dangers of foot complications and the advantages of early treatment, diabetic footwear especially ergonomic and medical-grade options become a standard part of managing diabetes.

Companies Mentioned

  • 1 . Apex Foot Health Industries, LLC
  • 2 . Enovis
  • 3 . Propet USA, Inc.
  • 4 . 3M Company
  • 5 . Essity AB
  • 6 . Simcan Enterprises Inc
  • 7 . Skechers Inc.
  • 8 . New Balance
Company mentioned

Table of Contents

  • Table 1: Global Diabetic Footwear Market Snapshot, By Segmentation (2025 & 2031F) (in USD Billion)
  • Table 2: Influencing Factors for Diabetic Footwear Market, 2025
  • Table 3: Top 10 Counties Economic Snapshot 2024
  • Table 4: Economic Snapshot of Other Prominent Countries 2022
  • Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 6: Middle East & Africa Diabetic Footwear Market Size and Forecast, By Product (2020 to 2031F) (In USD Billion)
  • Table 7: Middle East & Africa Diabetic Footwear Market Size and Forecast, By Foot Condition (2020 to 2031F) (In USD Billion)
  • Table 8: Middle East & Africa Diabetic Footwear Market Size and Forecast, By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 9: Middle East & Africa Diabetic Footwear Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 10: United Arab Emirates (UAE) Diabetic Footwear Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 11: United Arab Emirates (UAE) Diabetic Footwear Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 12: United Arab Emirates (UAE) Diabetic Footwear Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 13: Saudi Arabia Diabetic Footwear Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 14: Saudi Arabia Diabetic Footwear Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 15: Saudi Arabia Diabetic Footwear Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 16: South Africa Diabetic Footwear Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
  • Table 17: South Africa Diabetic Footwear Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 18: South Africa Diabetic Footwear Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 19: Competitive Dashboard of top 5 players, 2025

  • Figure 1: Global Diabetic Footwear Market Size (USD Billion) By Region, 2025 & 2031F
  • Figure 2: Market attractiveness Index, By Region 2031F
  • Figure 3: Market attractiveness Index, By Segment 2031F
  • Figure 4: Middle East & Africa Diabetic Footwear Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 5: Middle East & Africa Diabetic Footwear Market Share By Country (2025)
  • Figure 6: United Arab Emirates (UAE) Diabetic Footwear Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 7: Saudi Arabia Diabetic Footwear Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 8: South Africa Diabetic Footwear Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 9: Porter's Five Forces of Global Diabetic Footwear Market

Market Research FAQs

The increase is attributed to a higher rate of diabetes cases in the Middle East and Africa, growing awareness surrounding complications related to diabetic feet.
The shoe category holds the largest share as diabetic shoes offer comprehensive coverage, cushioning, and support, which are vital for preventing foot injuries, ulcers.
Neuropathy stands as the primary concern driving the need for diabetic footwear because it leads to nerve damage and a decrease in sensation.
Physical outlets such as specialty shops, clinics, and pharmacies are most commonly chosen since patients benefit from professional fittings, custom adjustments.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags